Business Description
Genflow Biosciences PLC
ISIN : GB00BP2C3V08
Description
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.68 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 95.38 | |||||
| 9-Day RSI | 89.21 | |||||
| 14-Day RSI | 84.88 | |||||
| 6-1 Month Momentum % | -15 | |||||
| 12-1 Month Momentum % | -46.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.09 | |||||
| Quick Ratio | 3.09 | |||||
| Cash Ratio | 1.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -101.6 | |||||
| ROA % | -87.25 | |||||
| ROIC % | -1013.28 | |||||
| ROC (Joel Greenblatt) % | -54266.67 | |||||
| ROCE % | -101.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.13 | |||||
| EV-to-EBIT | -5.38 | |||||
| EV-to-EBITDA | -5.38 | |||||
| EV-to-FCF | -4.28 | |||||
| Earnings Yield (Greenblatt) % | -18.61 | |||||
| FCF Yield % | -17.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genflow Biosciences PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.006 | ||
| Beta | 0 | ||
| Volatility % | 79.94 | ||
| 14-Day RSI | 84.88 | ||
| 14-Day ATR (€) | 0.004746 | ||
| 20-Day SMA (€) | 0.02285 | ||
| 12-1 Month Momentum % | -46.88 | ||
| 52-Week Range (€) | 0.011 - 0.038 | ||
| Shares Outstanding (Mil) | 349.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genflow Biosciences PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genflow Biosciences PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genflow Biosciences PLC Frequently Asked Questions
What is Genflow Biosciences PLC(FRA:WQ5)'s stock price today?
The current price of FRA:WQ5 is €0.03. The 52 week high of FRA:WQ5 is €0.04 and 52 week low is €0.01.
When is next earnings date of Genflow Biosciences PLC(FRA:WQ5)?
The next earnings date of Genflow Biosciences PLC(FRA:WQ5) is 2024-09-27 Est..
Does Genflow Biosciences PLC(FRA:WQ5) pay dividends? If so, how much?
Genflow Biosciences PLC(FRA:WQ5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers